🇺🇸 FDA
Patent

US 12115156

Compositions of CXCR4 inhibitors and methods of preparation and use

granted A61KA61K31/47A61K31/4709

Quick answer

US patent 12115156 (Compositions of CXCR4 inhibitors and methods of preparation and use) held by X4 Pharmaceuticals, Inc. expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
X4 Pharmaceuticals, Inc.
Grant date
Tue Oct 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/47, A61K31/4709, A61K9/485, A61K9/4858